Bluebird bio Inc (BLUE) — Capital Reinvestment Ratio

Latest as of June 2020: 0.12x

Bluebird bio Inc (BLUE) has a Capital Reinvestment Ratio of 0.12x as of June 2020, meaning it reinvests 0% of its operating cash flow ($39.74 Million) in capital expenditures ($4.80 Million). See BLUE net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.12x
Capex / Operating Cash Flow

Operating Cash Flow

$39.74 Million
USD

Capital Expenditures

$4.80 Million
USD

Data as of

Jun 2020
Most recent filing

Bluebird bio Inc Capital Reinvestment Ratio (2013–2013)

This chart tracks Bluebird bio Inc's Capital Reinvestment Ratio across 1 annual periods. Check BLUE total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Bluebird bio Inc (2013–2013)

Year-by-year Capital Reinvestment Ratio for Bluebird bio Inc from 2013 to 2013. For live market cap and broader valuation context, see BLUE market cap overview.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2013 0.20x $43.45 Million $8.67 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow